Naviaux’s small Suramin trial was successful. Could ME/CFS be next?

Autism is one of the most treatment resistant conditions there are – which is why the results of Bob Naviaux’s small autism drug trial were so surprising. Despite the fact that only one dose of the drug was given, every autistic child posted a significant response. In fact, test scores indicated that the group no longer met the criteria for autism.

That’s possibly very good news for ME/CFS given the similar metabolomic findings in both diseases, and Naviaux’s desire to do a similar trial in ME/CFS. Find out what happened in

Treating Autism and ME/CFS: Could One Drug Help Both?


Like the blog you're reading? Don't miss another one.

Get the most in-depth information available on the latest ME/CFS and FM treatment and research findings by registering for Health Rising's free  ME/CFS and Fibromyalgia blog here.

Stay on Top of the News!

Subscribe To Health Rising’s Free Information on Chronic Fatigue Syndrome (ME/CFS), Fibromyalgia (FM), Long COVID and Related Diseases.

Thank you for signing up!

Pin It on Pinterest

Share This